AMBROSE KRISTEN 1856587 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 2023-05-30 | 2023-05-30 | 4 | Ambrose Kristen | SVP & CHIEF ACCOUNTING OFFICER | dsp | 289.0 | 4.06 | 0.01 | 329.82 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 6838.0 | 257.55 (VRTX) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Ambrose Kristen | SVP & CHIEF ACCOUNTING OFFICER | acq | 4803.0 | 41.26 | 0.19 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 11641.0
|
257.68 (VRTX) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 to 2024-02-12 | 4 | Ambrose Kristen | SVP & CHIEF ACCOUNTING OFFICER | dsp | 1965.0 | 16.88 | 0.08 | 420.99 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 9676.0
|
257.68 (VRTX) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 to 2024-02-26 | 4 | Ambrose Kristen | SVP & CHIEF ACCOUNTING OFFICER | dsp | 1711.0 | 17.68 | 0.07 | 428.65 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 7965.0
|
258.31 (VRTX) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 to 2024-04-02 | 4 | Ambrose Kristen | SVP & CHIEF ACCOUNTING OFFICER | dsp | 465.0 | 5.84 | 0.02 | 418.56 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 7500.0
|
258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)